1. Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells
    Yangying Hu et al, 2022, Genes & Genomics CrossRef
  2. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis
    Xinxin Liu et al, 2024, Apoptosis CrossRef
  3. The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
    Man Wang et al, 2019, Cancers CrossRef
  4. The role of pyroptosis and its crosstalk with immune therapy in breast cancer
    Ling Wu et al, 2022, Frontiers in Immunology CrossRef
  5. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin
    Zaid H. Maayah et al, 2021, Archives of Toxicology CrossRef
  6. miR-223-3p Regulates NLRP3 to Inhibit Proliferation and Promote Apoptosis of ONG Cells
    Lili Nie et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  7. The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response
    Andrea Favero et al, 2021, WIREs RNA CrossRef
  8. Puerarin inactivates NLRP3-mediated pyroptotic cell death to alleviate cerebral ischemia/reperfusion (I/R) injury through modulating the LncRNA DUXAP8/miR-223-3p axis
    ZHENGUO SHI et al, 2022, BIOCELL CrossRef
  9. NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
    Vincenzo Quagliariello et al, 2020, International Journal of Molecular Sciences CrossRef
  10. NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia–Reperfusion Injury
    Lixia Wang et al, 2022, Frontiers in Molecular Neuroscience CrossRef
  11. Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
    Ting-Yi Lin et al, 2021, Frontiers in Immunology CrossRef
  12. NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
    Margherita Sonnessa et al, 2020, Frontiers in Oncology CrossRef
  13. The Inhibitory Effect of NLRP3 Deficiency in Hepatocellular Carcinoma SK-Hep1 Cells
    Wonhyeok Choi et al, 2021, Microbiology and Biotechnology Letters CrossRef
  14. NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications
    Xuhui Fang et al, 2021, Frontiers in Immunology CrossRef
  15. Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis
    Liliana R. Balahura et al, 2020, Journal of Immunology Research CrossRef